Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 USD | +1.64% | -0.40% | -59.67% |
May. 01 | Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 20M | Sales 2025 * | - | Capitalization | 17.34M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -54M | EV / Sales 2024 * | 0.87 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.4
x | P/E ratio 2025 * |
-0.69
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.74% |
Latest transcript on Minerva Neurosciences, Inc.
1 day | +1.64% | ||
1 week | -0.40% | ||
Current month | +5.09% | ||
1 month | -0.80% | ||
3 months | -74.82% | ||
6 months | -49.08% | ||
Current year | -59.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 14-02-28 | |
Geoff Race
FOU | Founder | 63 | 10-06-30 |
Fred Ahlholm
DFI | Director of Finance/CFO | 58 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeryl Hilleman
BRD | Director/Board Member | 66 | 18-07-16 |
Jan van Heek
BRD | Director/Board Member | 75 | 14-06-30 |
Director/Board Member | 68 | 17-12-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 2.48 | +1.64% | 17,049 |
24-05-13 | 2.44 | +2.10% | 13,468 |
24-05-10 | 2.39 | -4.78% | 20,962 |
24-05-09 | 2.51 | 0.00% | 2,153 |
24-05-08 | 2.51 | +0.80% | 5,226 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.67% | 17.34M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.32% | 21.25B | |
-5.99% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- NERV Stock